236 results
Page 4 of 12
424B5
qk1g0pbhfc23xeda
18 Jul 16
Prospectus supplement for primary offering
12:00am
424B5
67n 08ti2frrh0ki
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
4j5c9
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
w6x3zc
30 Nov 15
Current report (foreign)
12:00am
6-K
EX-99.1
tq7ytr1q rja7k
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
6-K
EX-99.2
djr j0xok
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
qpauubfl
8 Jun 15
Business combination disclosure
12:00am
425
fnx4ygtrna 4vgp5pyvz
21 Apr 15
Business combination disclosure
12:00am
425
uql8efv9y3g2b qf
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
657 vccpq
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
425
tt0m43n9gn8l6j
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
lrtnqfh3
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
t76efz i22gg77
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
yawaazer23or3qfk
2 Mar 15
Teva Announces Sale of Sellersville, PA Facility
12:00am
6-K
EX-99.1
ivf5fns6a6eox2uz4
5 Feb 15
Teva Reports Fourth Quarter and Full Year 2014 Results
12:00am
6-K
EX-99.1
bqawnjo pn
30 Oct 14
Teva Reports Third Quarter 2014 Results
12:00am
6-K
sa8yjwdhhp90g99fj ab
30 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
26orcjsj
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am